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Abstract
Multiple genetic variants have been associated with adult obesity and a few with severe obesity in 
childhood; however, less progress has been made to establish genetic influences on common 
early-onset obesity. We performed a North American-Australian-European collaborative meta-
analysis of fourteen studies consisting of 5,530 cases (≥95th percentile of body mass index (BMI)) 
and 8,318 controls (<50th percentile of BMI) of European ancestry. Taking forward the eight 
novel signals yielding association with P < 5×10−6 in to nine independent datasets (n = 2,818 
cases and 4,083 controls) we observed two loci that yielded a genome wide significant combined 
P-value, namely near OLFM4 on 13q14 (rs9568856; P=1.82×10−9; OR=1.22) and within HOXB5 
on 17q21 (rs9299; P=3.54×10−9; OR=1.14). Both loci continued to show association when 
including two extreme childhood obesity cohorts (n = 2,214 cases and 2,674 controls). Finally, 
these two loci yielded directionally consistent associations in the GIANT meta-analysis of adult 
BMI1.
Obesity is the major, increasingly prevalent health problem affecting modern societies. The 
problem is particularly severe for children in developed countries, where the prevalence of 
obesity is on the increase. Obesity present in adolescence is associated with increased 
overall mortality in later life2. Whereas the change in prevalence of obesity is likely to be 
explained by environmental changes over the last 30 years, there is also strong evidence for 
a genetic component to the risk of obesity. This is reflected in familial occurrences of 
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childhood obesity, where concordance for fat mass among monozygotic twins is reported to 
be higher than in dizygotic twins.
In the past four years, many genetic loci have been implicated for body mass index (BMI) / 
obesity from the outcomes of genome-wide association studies (GWAS), primarily in adults. 
The first locus reliably found to harbor variation associated with adiposity, the fat mass- and 
obesity-associated gene (FTO)3, has been shown subsequently to be associated with obesity 
in all sufficiently sized study groups. Subsequent larger studies have revealed additional 
BMI/obesity genes. The largest meta-analysis of adult BMI to date came from the GIANT 
consortium, which confirmed fourteen known obesity susceptibility loci and revealed 
eighteen new loci associated with BMI in a study involving a total of 249,796 individuals1. 
However, these loci only account for a small fraction of the heritability that is known to 
contribute to obesity. There has been some work on extreme obesity in childhood (>99.5th 
percentile of BMI) but little progress has been made on less marked definitions of obesity 
more relevant to public health.
We reasoned that distillation of the genetic component in this complex phenotype should be 
easier in children, where environmental exposure and impact has been for a relatively short 
period of their lifetime. The relationship between BMI and body fat in children varies 
widely with age and with pubertal maturation. The Center for Disease Control and 
Prevention defined overweight as at or above the 95th percentile of BMI for age4. By late 
adolescence, these percentiles approach those used for adult definitions; the 95th percentile 
is then approximately 30 kg/m2 5.
In an effort to systematically search for childhood obesity susceptibility loci, we performed 
a large scale meta-analysis of fourteen existing GWAS datasets for childhood obesity, 
totaling 5,530 cases (≥95th percentile of BMI achieved before the age of 18 years old, 
representing 5–30% of any given cohort) and 8,318 controls (relatively conservatively 
defined as <50th percentile of BMI consistent throughout all measures during childhood) of 
European ancestry (see Supplementary Table 1 and Supplementary Note).\
Following the meta-analysis of 2.7 million SNPs (directly genotyped or imputed), signals at 
seven discrete locations reached genome-wide significance at P < 5.0×10−8. All these loci 
have been previously reported within GWAS for adult BMI (FTO, TMEM18, POMC, 
MC4R, FAIM2, TNNI3K and SEC16B), and robustly reflect previous reports on individual 
pediatric cohorts6,7. FTO gave the strongest evidence for association while TNNI3K and 
POMC, which were only detected in adult studies when using hundreds of thousands of 
participants, were readily detected in our relatively small sample size (Figure 1 and 
Supplementary Tables 2 and 3). Excluding the French and German studies from the meta-
analysis, we did not observe association with variants previously reported by these groups as 
novel, where they defined childhood obesity was at a higher threshold8, at the loci harboring 
TNKS-MSRA (rs17150703; P = 0.22) and SDCCAG8 (rs12145833; P = 0.57).
We took forward all eight novel signals yielding association with P < 5.0×10−6 (Table 1 and 
Supplementary Table 4, the latter of which includes a heterogeneity analysis showing that 
the different distributions in each study did not affect our results; in addition Supplementary 
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Table 5 shows the results after applying a second genomic control correction to the overall 
discovery meta-analysis results) in order to test for replication in multiple independent 
existing datasets, the majority of which were in silico analyses. In our replication effort, we 
initially tested these eight SNPs in nine study groups that had a comparable set of affected 
subjects i.e. BMI distributed normally from the 95th percentile upwards (n = 2,818 cases and 
4,083 controls). From this attempt we observed two loci that yielded consistent evidence of 
association when combined with the discovery cohort, namely near olfactomedin 4 
(OLFM4) on 13q14 (rs9568856; Pcombined = 1.82×10−9; OR = 1.22) and within the gene 
encoding homeobox B5 (HOXB5) on 17q21 (rs9299; Pcombined = 3.54×10−9; OR = 1.14) 
(Table 1; see also the regional plots in Supplementary Figures 1 and 2 for the discovery 
meta-analysis data).
Previous GWAS reports for extreme obesity case-control samples have demonstrated both 
confirmation of signals seen in less extreme or population based samples, such as FTO, as 
well as novel signals that are distinct from those seen at the population level8. We reasoned 
therefore that further exploration in existing extreme datasets [two cohorts totaling 2,214 
cases (exclusively individuals approximately >4 standard deviations above the mean, 
equating to BMI>99.5th percentile] and 2,674 controls) would offer further insight in to how 
these signals operate, acknowledging the phenotypic differences and limits of sample size. 
Indeed, both loci emerging from the main replication step continued to show association 
folding in this more extreme phenotype (OLFM4; rs4833407; Poverall = 5.33×10−9; OR = 
1.18 and HOXB5; rs9299; Poverall = 1.54×10−8; OR = 1.13) (Supplementary Table 6).
As the ALSPAC cohort leveraged BMI measures made before the age of two years old as 
part of defining cases and controls, we ran sensitivity analyses limiting case and control 
definitions to children over two years of age (Supplementary Tables 7–9). In addition to no 
diminishment in the odds ratios for the OLFM4 and HOXB5 loci, we observed support for 
rs4864201 at BC041448 and rs4833407 at ALPK1 (Supplementary Tables 8 and 9).
Finally, we were interested to see whether our two main signals of interest, namely at 
OLFM4 and HOXB5, were evident in the GIANT adult BMI meta-analysis results (n = 
123,864). Indeed, both loci yielded evidence of association in this quantitative setting (P-
values= 7.75×10−5 and 0.015, respectively) with the same alleles in the same direction. 
Overall, seven of the eight signals initially taken forward in to the replication stage yielded 
consistent directionality, albeit not all being statistically significant, with the exception being 
rs1290002 (Supplementary Table 10).
Overall, these data indicate that the genetic architecture of BMI and obesity overlap to a 
large extent in children as well as adults. In addition to the previously reported loci, we have 
uncovered at least two new loci associated with obesity in early life. The adult BMI data 
available from GIANT1 reveals that the influence of these two loci is also detected in 
adulthood. Interestingly, in addition to OLFM4 and HOXB5, GIANT also supports an 
association with three more of the eight loci initially taken forward in to the replication 
effort, namely rs4864201 at BC041448, rs4833407 at ALPK1 and rs2300095 at 
MTORANGPTL7 loci, despite these signals not formally replicating in the main defined 
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overall pediatric setting, suggesting that these loci should be followed up further to fully 
understand their role in the pathogenesis of obesity as a whole.
The gene encoding olfactomedin 4 (OLFM4) is the nearest gene to rs9568856 but is still 
approximately 500kb from the associated signal; the gene product has never been directly 
implicated in obesity but has been extensively studied in the context of various cancers. 
OLFM4 is a secreted glycoprotein that facilitates cell adhesion via lectins and cadherin on 
the cell surface. Although the function of OLFM4 is not well understood, there are several 
intriguing observations that link it to gut microflora and to a relationship between the gut 
microbiome and obesity risk. For example, the OLFM4 gene product down regulates innate 
immunity against infection by the stomach bacterium, Helicobacter pylori9, with obese 
subjects having a higher occurrence of Helicobacter pylori infection than lean 
counterparts10,11; indeed, weight-loss induced by obesity surgery eradicates Helicobacter 
pylori12.
rs9299 is in the 3’ untranslated region of the gene encoding homeobox B5 (HOXB5) within 
a homeobox B cluster. HOXB5 is spatially and temporarily regulated during gut 
development13, but its role in obesity has been suggested by a study observing up-regulation 
of homeobox transcription factors after fat loss14. Taken together, it is possible that OLFM4 
and HOXB5 may impact BMI via different aspects of gut function.
In summary, as a consequence of extensive North American-Australian-European 
collaborative genome-wide meta-analyses on children, we have uncovered two novel obesity 
loci which have their strongest evidence for association with elevated adiposity in the first 
eighteen years of life. Further functional characterization of these signals is required to 
elucidate the precise mechanism behind these observations.
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Figure 1. 
Manhattan Plot of the meta-analysis of childhood obesity GWAS runs in the discovery stage 
(5,530 cases and 8,318 controls), with each locus achieving genome wide significance (P < 
5×10−8) indicated in black text. In addition, the novel loci uncovered in this study are 
indicated in red text.
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